Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Recruiting · NCT05413421 · Registry updated 2026-07-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of ORIC-944 in Patients With Metastatic Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 | 2026-07-09 | NCT05413421 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ORIC Pharmaceuticals | 4 |
27 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.